精准医学杂志2024，Vol.39Issue(4)：371-373,375,4.DOI:10.13362/j.jpmed.202404019
18F-FDG PET/CT与肿瘤标志物NSE和ProGRP在小细胞肺癌诊疗中的应用
The application of 18 F-FDG PET/CT with tumor markers NSE and ProGRP in the diagnosis and treatment of small cell lung cancer
摘要
Abstract
Small cell lung cancer(SCLC)is the most common neuroendocrine tumor in the lungs.SCLC is characterized by high malignancy and high recurrence and metastasis rates.The improvement of the prognosis of patients with SCLC relies on early diagnosis,correct staging,and accurate assessment of efficacy and prognosis.In this paper,we comprehensively analyze the application progress of 18F-fluorodeoxyglucose(FDG)PET/CT as well as the tumor markers neuron-specific enolase(NSE)and gastrin-releasing peptide precursor(ProGRP)in the diagnosis and treatment of SCLC.Our results can be useful for the diagnosis and treatment of SCLC patients in clinical practice.关键词
小细胞肺癌/氟脱氧葡萄糖F18/正电子发射断层显像计算机体层摄影术/磷酸丙酮酸水合酶/胃泌素释放肽/蛋白质前体/生物标记,肿瘤Key words
Small cell lung carcinoma/Fluorodeoxyglucose F18/Positron emission tomography computed tomography/Phosphopyruvate hydratase/Gastrin-releasing peptide/Protein precursors/Biomarkers,tumor分类
医药卫生引用本文复制引用
林帅,王艳丽..18F-FDG PET/CT与肿瘤标志物NSE和ProGRP在小细胞肺癌诊疗中的应用[J].精准医学杂志,2024,39(4):371-373,375,4.基金项目
青岛市医药卫生科研计划项目(2021-WJZD067) （2021-WJZD067）
